We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Arachidonic Acid Stimulates Cancer Growth

By Biotechdaily staff writers
Posted on 16 Feb 2006
Researchers have found that arachidonic acid, an omega-6 fatty acid, stimulated the growth of tumor cells by activating the metabolic pathway leading to prostaglandin synthesis and translocation to the nucleus of nuclear factor-kappaB (NF-kappaB).

Investigators at the San Francisco Veterans Administration Medical Center (CA, USA) added arachidonic acid to human prostate tumor cells growing in tissue culture. More...
They found that this prompted the cells to grow at a rate nearly double that of control cells that did not receive arachidonic acid.

Analysis using gene chip technology showed that arachidonic acid induced 11 genes that were regulated by NF-kappaB. Within five minutes of addition of arachidonic acid prostaglandin E2 (PGE2) synthesis was increased, and analysis of upstream signal transduction showed that phosphatidylinositol 3-kinase (PI3K) was significantly activated. These events were followed by activation of Akt at 30 minutes, when a significant three-fold increase in translocation of NF-kappaB to the nucleus was seen. Interruption of the pathway by treatment with either a COX-2 inhibitor or with a PI3K inhibitor reversed the stimulatory effect of arachidonic acid. These findings were published in the February 1, 2006, issue of Cancer Research.

Senior author Dr. Mille Hughes-Fulford, director of the Laboratory of Cell Growth at the San Francisco Veterans Administration Medical Center, said, "Investigating the reasons for this rapid growth, we discovered that the omega-6 was turning on a dozen inflammatory genes that are known to be important in cancer. We then asked what was turning on those genes, and found that omega-6 fatty acids actually turn on a signal pathway called PI3-kinase that is known to be a key player in cancer. I am not a physician, and do not tell people how to eat, but in my own home I use only canola oil and olive oil. We do not eat deep-fried foods.”



Related Links:
San Francisco Veterans Administration Medical Center

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The addition of Biocare’s complementary IHC antibody, reagent and instrument portfolio enhances Agilent’s immunohistochemistry offering (Photo courtesy of Biocare Medical)

Agilent Technologies Acquires Pathology Diagnostics Company Biocare Medical

Agilent Technologies (Santa Clara, CA, USA) has entered into a definitive agreement to acquire Biocare Medical (Pacheco, CA, USA), expanding its pathology portfolio through the addition of highly complementary... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.